2018 cohort company Ejenta partnered with Point3Health, the parent organization of Harvard Pilgrim Health Care and Tufts Health Plan, on a pilot aimed at improving the health of its members with congestive heart failure. Learn more here.
2018 cohort company Lapovations has signed distribution agreements with VersaMed, LLC, EPL Surgical, and Edge Surgical, to provide sales and distribution for their flagship product, AbGrab®. Learn more here, here, and here.
2018 cohort company Macro-Eyes was selected as the winner of the Assistant Secretary of the Army for Acquisition, Logistics and Technology's (ASA(ALT)) xTechSearch 6 proof-of-concept finals held at the AUSA Conference in Arlington, Virginia. The Macro-Eyes Vision Based Inventory Management (VBIM) mobile-based supply chain technology was selected from 19 finalists, narrowed down from more than 200 companies. Learn more here.
2019 cohort company Health Note announced the close of a $17 million Series A financing round led by SignalFire. SignalFire is joined by UnityPoint Health, Northwell Holdings, the for-profit arm of Northwell Health focused on investment in early stage/growth opportunities, strategic partnerships and the cultivation of internal innovations that drive improvements in patient care and create diversified revenue streams for the health system, and Cedars Sinai Health Ventures. Learn more here.
2020 cohort company nView Medical surpassed its landmark 100th clinical case with the help of 22 surgeons at six leading pediatric facilities, including three of the top 10 facilities in the nation. Over the course of the first 100 cases, nView medical achieved FDA clearance of its integrated true-map navigationTM system, making the nView s1 the only integrated imaging and navigation system specifically designed for pediatric surgery. Learn more here.
2020 cohort company Zeto is now offering its customers a remote electroencephalography (EEG) reading service. This was made possible through a partnership with a physician-led organization dedicated to providing expert, high-quality telehealth-assisted EEG interpretation to hospitals and outpatient settings, regardless of geographic location. Learn more here.
2021 cohort company Genetesis announced that it has closed $17.5 million in Series C Financing. The round was led by Mithril Capital with participation from Cercano Management as well as from existing investors, including JobsOhio Growth Capital, Ohio Innovation Fund and CincyTech. This investment brings the company’s total funding to over $40 million. Learn more here.
2021 cohort company Moving Analytics has raised $20 million in a round co-led by Seae Ventures and Wellington Access Ventures. Learn more here.
2021 cohort company SoniVie announced that the first patient was treated with its Renal Artery Denervation TIVUS™ technology, as part of the recently FDA IDE-approved pilot study to treat hypertension. Learn more here.